Alzamend Neuro annual depreciation and amortization
2022
2023
2024
2025
2026
Alzamend Neuro Depreciation & Amortization Growth & History (ALZN)
Alzamend Neuro's depreciation and amortization was $110,740 for fiscal 2026.
View full Alzamend Neuro company overviewAlzamend Neuro annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-30 | $110,740 | $60,000 | +118.25% |
| 2025 | 2025-04-30 | $50,740 | $0 | 0.00% |
| 2024 | 2024-04-30 | $50,740 | $27,674 | +119.98% |
| 2023 | 2023-04-30 | $23,066 | $19,517 | +549.93% |
| 2022 | 2022-04-30 | $3,549 | — | — |
Alzamend Neuro quarterly depreciation and amortization
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-04-30 | $27,685 | $15,000 | +118.25% |
| Q3 2026 | 2026-01-31 | $27,685 | $15,000 | +118.25% |
| Q2 2026 | 2025-10-31 | $27,685 | $15,000 | +118.25% |
| Q1 2026 | 2025-07-31 | $27,685 | $15,000 | +118.25% |
| Q4 2025 | 2025-04-30 | $12,685 | — | — |
| Q3 2025 | 2025-01-31 | $12,685 | $0 | 0.00% |
| Q2 2025 | 2024-10-31 | $12,685 | $0 | 0.00% |
| Q1 2025 | 2024-07-31 | $12,685 | $0 | 0.00% |
| Q3 2024 | 2024-01-31 | $12,685 | $7,362 | +138.31% |
| Q2 2024 | 2023-10-31 | $12,685 | $7,362 | +138.31% |
| Q1 2024 | 2023-07-31 | $12,685 | $5,588 | +78.74% |
| Q3 2023 | 2023-01-31 | $5,323 | — | — |
| Q2 2023 | 2022-10-31 | $5,323 | — | — |
| Q1 2023 | 2022-07-31 | $7,097 | — | — |
Alzamend Neuro depreciation and amortization trends
Between the periods ended 2022-04-30 and 2026-04-30, Alzamend Neuro's depreciation and amortization increased from $3,549 to $110,740, a change of $107,191. The latest reported quarter, Q4 2026, shows $27,685.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alzamend Neuro source filings ↗